this is crushing news to the stem cell industry
No it is not. It is one company who has not succeded within this sector. A sector which will, eventually, be a new era for humanity.
I can understand your frustration I too have been hit heavily by these losses. But I've diversified within this sector AND HOPE YOU HAVE ALSO!
How I'm positioned:
- 40% of my portfolio is with NBS (BY A LONG WAY, THE SAFEST PLAY IN THE SECTOR, it's also starting to run these days)
- 20% is with ATHX
- 10% on OSIR
- 15% on IMUC
- 5% each on CUR, PSTI and ACTC
There is huge profits to be made in this sector. I for one plan on cashing in on the loot!